September 25, 2007

Chemical Engineer Daniel Wang Discusses the Use of Animal Cells in Biopharmaceuticals

Lecture on Sept. 27 is part of Interdisciplinary Seminar Series in the Life Sciences

The Interdisciplinary Seminar Series in the Life Sciences will present Daniel I.C. Wang, professor of chemical engineering at the Massachusetts Institute of Technology and Temasek Professor in the Bioprocessing Technology Centre of the National University of Singapore, 7 p.m. Sept. 27 in room 224 of Oechsle Hall.

Wang’s lecture, “Biotechnology of Mammalian Cells: Present Status and Future Perspectives,” is sponsored by the Fund for Faculty Innovation from the Office of the Provost. A reception will follow.

The presentation by Wang will begin by reviewing the status of biotechnology in the United States. The past achievements that have been developed in cell culture will be highlighted along with scientific and technological achievements in research, development, and manufacturing using cell culture.

Because there is the prediction that the biopharmaceutical products from cell cultures will be used for treatment of chronic human diseases, the presentation will also highlight the technical challenges of creating products at lower manufacturing costs and the research and development opportunities for universities and industry.

Wang founded the Biotechnology Process Engineering Center through the National Science Foundation Engineering Research Center Initiative and acted as its Director from 1985 to 1998. He has been elected to the American Academy of Arts and Sciences, the National Academy of Engineering, the American Institute of Medical and Biological Engineering, the Academia Sinica (Republic of China), and the International Institute of Biotechnology.

Wang has authored and co-authored five books, over 230 publications, and holds 15 patents. He resides and has resided as an editorial board member for eight scientific journals. He has consulted for over 50 companies world-wide and is on the Board of Directors and Scientific Advisory Boards on a number of public and private companies.

His present research areas include animal cell biotechnology, nanotechnology in bioprocesses, glycosylation in glycoprotein biopharmaceuticals, enzyme biocatalysis, protein stabilization, and renewable resource utilization.

Wang received his Ph.D. degree in Chemical Engineering in 1963 from the University of Pennsylvania. He received his B.S. in Chemical Engineering in 1959 and his M.S. in Biochemical Engineering in 1961 both from MIT.

The Interdisciplinary Seminar Series in the Life Sciences has come about through the efforts of nine professors across six academic departments to help the Lafayette community gain a better understanding of the fundamental principles of research in biology, chemistry, engineering, and environmental science.

As well as lecturing, invited speakers will meet with interested students and faculty. In these meetings, students will have the opportunity to discuss the science being presented and gain alternative perspectives on future careers in the field. Faculty will also have the opportunity to show the speakers the research they and their students are doing here at Lafayette.

Previous series speakers:

  • Marine Biologist Will Discuss Mercury Contamination in Fish
  • Biochemist Will Discuss Role of Photosynthesis in the History of Life
  • Polytechnic University Professor Will Speak about Biomedical Fluid Dynamics
  • Marine Geologist Rebecca S. Robinson Will Lecture as Part of Life Sciences Series
  • College Organizes Interdisciplinary Series on the Life Sciences

posted in Collaborative, High-Impact Learning, Engineering, News and Features

tagged with , , , ,